Day 1, n= 164 | Day 1-3, n= 95 | |||||
---|---|---|---|---|---|---|
High fluid volume (> 4.0 L), n = 82 | Low fluid volume (< 4.0 L), n = 82 | P value | High fluid volume (> 7.5 L), n = 47 | Low fluid volume (< 7.5 L), n = 48 | P value | |
Total fluid volume, liters | 6.3 (5.1-8.2) | 2.3 (1.1-3.0) | < 0.0001 | 10.9 (8.7-13.3) | 4.3 (3.0-5.7) | < 0.0001 |
Crystalloids, liters | 3.9 (3.0-6.0) | 2.0 (1.0-2.3), n = 59 | < 0.0001 | 7.0 (4.5-9.8) | 2.8 (0.5-4.3), n = 40 | < 0.0001 |
Colloids, liters | 1.1 (0.6-1.6), n = 72 | 0.5 (0.4-1.0), n = 64 | < 0.0001 | 2.1 (1.0-2.5), n = 46 | 1.0 (0.5-1.5), n = 40 | < 0.0001 |
Blood products, liters | 1.2 (0.6-2.8), n = 53 | 0.5 (0.2-0.9), n = 34 | < 0.0001 | 2.6 (1.1-4.3), n = 41 | 1.1 (0.5-1.9), n = 32 | < 0.001 |
SAPS II on admission | 54 (45-64) | 54 (45-67) | 0.73 | 53 (46-67) | 55 (49-62) | 0.47 |
SOFA scorea | 11 (9-13) | 11 (9-13) | 0.99 | 10 (8-13) | 11 (10-14) | 0.33 |
Maximum p-lactate in mmol/La | 3.4 (2.2-5.5) | 2.0 (1.6-3.2), n = 81 | < 0.0001 | 2.6 (1.7-3.4) | 1.9 (1.6-2.4) | < 0.01 |
Minimum ScvO2, percentagea | 70 (63-77), n = 68 | 73 (66-78), n = 57 | 0.26 | 74 (66-80), n = 34 | 74 (68-79), n = 31 | 0.35 |
Maximum vasopressor in μg/kg per minutea | 0.25 (0.12-0.43) | 0.18 (0.10-0.32) | 0.07 | 0.16 (0.10-0.24) | 0.15 (0.08-0.22) | 0.57 |
Renal replacement therapy, number (percentage) | 32 (39) | 32 (39) | 1.00 | 18 (38) | 16 (33) | 0.61 |
90-day mortality, number (percentage) | 38 (46) | 45 (55) | 0.27 | 19 (40) | 29 (62) | 0.03 |